Orexo announces positive data for powder-based intranasal vaccine formulated with the AmorphOX technology ...Middle East

The study was conducted in partnership with Abera Bioscience, a platform and vaccine developer with over 30 years of research in the medical, molecular and microbiological fields. Both formulations tested induced strong systemic antibody response in serum (IgG) as well as locally in the...

Read More Details
Finally We wish PressBee provided you with enough information of ( Orexo announces positive data for powder-based intranasal vaccine formulated with the AmorphOX technology )

Also on site :

• Japan inflation comes in at 3.6%, surpasses BOJ target for three straight years
• KI-gestütztes Wohnen auf der 137. Canton Fair vorgestellt
• Europe’s Energy Transition Stutters, Again